Park City Lymphoma Myeloma Conference

By -Elaina Harris

May 20, 2024

This CME-accredited activity, Park City Lymphoma Myeloma Conference, features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia.

This activity aims to improve learners’ knowledge and competence to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical contexts and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Binaytara Foundation Summit on Cancer Health Disparities 2024

Binaytara Foundation Summit on Cancer Health Disparities 2024

Binaytara Foundation October Conference Recap

Binaytara Foundation October Conference Recap

Summit on Cancer Health Disparities Presents Research on Inequities in Cancer Care

Summit on Cancer Health Disparities Presents Research on Inequities in Cancer Care